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Abstract
Cardiovascular diseases represent a major health problem, being one of the leading causes of morbidity and mortality
worldwide. Therefore, in this scenario, cardiovascular prevention plays an essential role although it is difficult to establish
when promoting and implementing preventive strategies. However, there is growing evidence that prevention should
start even before birth, during pregnancy, aiming to avoid the onset of cardiovascular risk factors, since events that occur
early in life have a great impact on the cardiovascular risk profile of an adult. The two pillars of this early preventive
strategy are nutrition and physical exercise, together with prevention of cardio-metabolic diseases during pregnancy. This
review attempts to gather the growing evidence of the benefits of antenatal, perinatal and primordial prevention,
discussing also the possibility to reverse or to mitigate the cardiovascular profile developed in the initial stages of life.
This could pave the way for future research, investigating the optimal time and duration of these preventing measures,
their duration and maintenance in adulthood, and the most effective interventions according to the different age and
guiding in the next years, the best clinical practice and the political strategies to cope with cardiovascular disease.
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Background
Atherosclerotic cardiovascular diseases (ASCVDs)
have a great impact on general health and on socio-
economic burden, being one of the leading causes of
morbidity and mortality worldwide.1 Therefore, the
major ASCVD risk factors have relevant consequences
on overall health. Over recent years, an increasing
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number of chronic diseases has been observed, espe-
cially metabolic disorders such as diabetes mellitus
and obesity, which are known to have a relevant
impact on ASCVD risk.2 Contrary to common belief,
this phenomenon does not involve only adults and the
elderly, but it has been gaining relevant weight among
adolescents and young adults, being able to influence
each stage of life.3 Therefore, the events occurring in
the early phases of life might have a great impact on the
future ASCVD risk. For these reasons, ASCVD pre-
vention should start as soon as possible, in order to
avoid the onset of predisposing factors that might
affect individual health later in life. Therefore, the pre-
vention strategies that the family and the mother might
follow before pregnancy and the measures that could be
taken to provide the best maternal environment for the
foetus (antenatal and perinatal prevention) have
assumed a relevant role to avoid the onset of predispos-
ing ASCVD risk factors together with primordial pre-
vention, that is, the implementation of interventions set
to avoid the onset of ASCVD risk factors once the baby
is born.4 This review attempts to gather the growing
evidence of the benefits of these prevention strategies,
also discussing whether the ASCVD profile developed
in the initial stages of life can be reversed or mitigated.
We have based our paper on the research on PubMed
literature, without posing a time limit. The primary
search used the following keywords: primordial preven-
tion, pre-eclampsia and cardiovascular risk, pre-terms
and cardiovascular risk, gestational diabetes, nutrition
in children, physical activity in children, childhood
obesity, adolescents and cardiovascular risk. Articles
not in English and not on humans were not included.
Notably, this is a literature review and not a systematic
review: take-home messages of the single studies have
been reported but data were not extracted and
analysed.
The role of intra-uterine life
There is growing evidence that events that occur during
intrauterine life have a great impact on the ASCVD risk
profile of the child, which might even be sustained later
in life, as Barker et al. started investigating almost
30 years ago.5,6 Pregnancy-related hypertensive dis-
orders, gestational diabetes, pre-term birth and parents’
behaviour as well as physiological imbalances have
emerged as the most relevant factors having an
impact on the ASCVD risk profile. Indeed, there is
growing evidence that parental smoking during preg-
nancy has an important impact on the development
of cardiovascular risk factors in children7,8 and adoles-
cents, which might be sustained even in adulthood.9 In
particular, several studies have suggested the associ-
ation between maternal smoking and offspring
obesity,10 and in general with paediatric cardiovascular
morbidity.11 Furthermore, maternal anxiety and
depression during pregnancy, mainly in the last trimes-
ter, might have an impact on the health of the off-
spring,12 especially on the cardiovascular responses to
stress.13 This highlights the importance of early
ASCVD prevention, both in the mothers and in the
offspring, especially in light of the possible association
of pre-pregnancy factors with negative effects on the
newborn, such as the connection that has been recently
drawn between maternal body mass index before preg-
nancy and blood pressure in the offspring.14
Pregnancy-related hypertensive disorders
During pregnancy the cardiovascular system undergoes
significant changes that lead to a progressive reduction
of blood pressure (BP) until the trend is reverse toward
the end of the gestational period, when the BP reaches
the highest values.15 This physiological phenomenon
guarantees an optimal placental functioning, laying
the basis for a better outcome.16 On the other hand,
both the mother and the offspring’s outcome are nega-
tively affected by an abnormal elevated BP during the
third trimester, since that could predispose to pre-term
delivery, low birth weight and pre-eclampsia,17,18 and it
has been recently found associated with a higher off-
spring BP.19 Gestational hypertension is defined as new
onset of elevated BP after the 20th week of pregnancy,
whereas pre-eclampsia is a complex syndrome with ele-
vated BP associated with proteinuria. Its pathophysio-
logical basis is characterized by increased levels of
antiangiogenetic factors that impair the normal placen-
tal function, which then leads to foetal hypoxia.20 It has
been widely proven that this syndrome is responsible
for an augmented morbidity and mortality in both the
mother and the offspring20 and is associated with endo-
thelial dysfunction21 and with changes in retinal micro-
circulation.22 This finding stresses the role of retinal
microcirculation as an accessible site to analyse sys-
temic human microcirculation. Indeed, changes in ret-
inal microcirculation, such as a reduced diameter of
retinal arterioles, are correlated with both systemic
hypertension and ASCVD outcome, including the risk
of stroke and ASCVD mortality, and are early markers
of vascular impairment, such as intima-media thickness
and coronary calcification.23
Both fluctuating BP and hypoxia have also an
impact on the morpho-functional development of the
myocardium;24 as a consequence, systemic hyperten-
sion, and in particular pre-eclampsia, may affect the
myocardial development and its remodelling. In par-
ticular, offspring exposed to pre-eclampsia tend to
show a geometrical pattern of the myocardium that
goes toward a concentric remodelling, being
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characterized by an increased relative wall thickness
(RWT), a reduced left ventricular (LV) end-diastolic
diameter but a similar left ventricular mass index
(LVMI) compared with offspring exposed to normal
BP during pregnancy.25 If the mother is affected by
gestational hypertension, the newborn is prone to
have an augmented RWT without any changes in LV
diameters.25 Furthermore, fluctuating systolic BP in the
early stages of pregnancy, in particular between the
eighth and the 18th weeks, is associated with larger
LVMI and LV end-diastolic volume, and less optimal
LV diastolic function, evaluated through the E/A
ratio.25 Regarding the impact of pre-eclampsia on the
ASCVD risk profile of the offspring, several studies
have demonstrated that it might be associated with
higher BP and body mass index (BMI) during child-
hood and adolescence,26 and an increased risk of
stroke in adulthood, as compared with offspring not
exposed to pre-eclampsia.27 These findings may need
to be considered in future primary prevention strategies
for cardiovascular disease. A recent meta-analysis con-
firmed the effects of pre-eclampsia on the BP profile of
the offspring, although it has not been yet clarified
whether its impact is more relevant for systolic, as the
majority of the studies have attested, or diastolic BP.28
Therefore, the current evidence suggests that preg-
nancy-related hypertensive disorders might significantly
influence the ASCVD risk profile of the offspring, sup-
porting the concept that an appropriate management
and treatment of these conditions may play a relevant
role as a preventive measure.
Maternal diabetes
Changes during pregnancy do not affect only the car-
diovascular system but also the hormonal and meta-
bolic profile. Indeed, after the first trimester the
glucose blood levels tend to progressively increase, sus-
tained by a physiological insulin-resistance, which guar-
antees an optimal glucose supply to the foetus.
However, when this insulin-resistance is exacerbated,
these metabolic compensations go beyond the normal
range, resulting in maternal hyperglycaemia and gesta-
tional diabetes (GDM). GDM is defined as glucose
intolerance that develops in the second or third trimes-
ter of pregnancy and that leads to maternal hypergly-
caemia.29 GDM determines an increased risk of
pregnancy complications, such as shoulder dystocia,
macrosomia and foetal hypoglycaemia, together with
negative long-term effects for the mother and the
child.30 In particular, diabetic mothers have a higher
risk of developing type II diabetes mellitus and
ASCVD later in life.31 Furthermore, the rate of obesity,
systemic hypertension, metabolic syndrome and obesity
increases and these conditions are known to have a
great impact on cardiovascular health.32 As in gesta-
tional hypertensive disorders, the intra-uterine expos-
ure to a diabetic environment could determine a
cardiac remodelling in the exposed offspring. Indeed,
GDM has been associated with an increased rate of
cardiac abnormalities,33 with the most common anom-
aly being an asymmetrical myocardial hypertrophy,
often localized in the interventricular septum.34
Diastolic dysfunction is the primarily manifestation of
this foetal cardiovascular dysfunction, which later
might evolve into systolic impairment.35 An early ven-
tricular dysfunction caused by intra-uterine exposure to
a diabetic environment has been confirmed also by
echocardiographic studies analysing myocardial
deformation: Miranda et al. have confirmed that
during the third trimester diastolic strain rate values
of both ventricles were significantly lower in exposed
versus unexposed foetuses and systolic function of the
right ventricle (RV) is more likely to be impaired com-
pared with the LV, as demonstrated by a lower global
longitudinal strain in the former.36 Several possible
explanations have been proposed, such as the central
role of the RV in the foetal circulation and the correl-
ation between RV mass alterations and the need for
postnatal ventilation.
Therefore, the current evidence suggests that intra-
uterine exposure to a diabetic environment may have
an impact on biventricular geometry and function later
in life, underlining the need for an adequate control of
maternal glycaemia to reduce the negative effects for
the foetus of hyperglycaemia.
Low-grade systemic inflammation
Over the years attention has been focused on the role of
systemic inflammation as an important determinant of
ASCVD. The relevance of this concept has been tested
in several lipid-lowering trials, demonstrating the pres-
ence of a certain degree of residual systemic inflamma-
tion despite drug treatment, as suggested by high levels
of high-sensitivity reactive C-protein, in patients with a
prior myocardial infarction, which was also associated
with a higher risk of re-infarction, stroke and mortal-
ity.37 A latent systemic inflammation can be found also
during pregnancy if pathological changes occur and
might have a relevant repercussion on the offspring.
Indeed, pre-eclampsia is characterized by placental
and systemic inflammation, which tends to persist
even after delivery and which causes a certain level of
endothelial dysfunction.38 Moreover, a study has
shown that female offspring of mothers affected by
type I diabetes mellitus are characterized by a higher
level of the soluble form of the haptoglobin–haemoglo-
bin scavenger receptor CD163, a marker of inflamma-
tion.39 Notably, recent investigations have associated
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this marker with obesity-related low-grade inflamma-
tion and future development of type II diabetes melli-
tus.40,41 Indeed, inflammation plays a significant role
even later in life, since the presence of visceral fat, as
it occurs with obesity, is a source of pro-inflammatory
cytokines,42 which are able to induce endothelial
impairment, paving the way for arterial hypertension
to occur.
Is it possible to prevent adverse cardiac remodelling?
Hypertensive disorders during pregnancy and GDM
have a great impact on the ASCVD risk profile of the
exposed offspring and this prompts the question of
whether these effects might be prevented or at least
reversed by taking into account particular preventive
measures. Currently, although the evidence is still
scarce, the role of physical activity and nutrition pre-
dominates in preventing the onset of these disorders.
Unfortunately, there is a lack of large scale clinical
trials investigating the hypothesis that physical activity
and/or diet might reverse the foetal cardiac remodelling
once it has occurred. Therefore, beyond the general
beneficial effects of an adequate nutrition and physical
activity, the most important strategy to apply in this
phase of the life is to prevent metabolic and hyperten-
sive diseases during pregnancy. If prenatal exercise has
been found to be a valuable measure in reducing the
incidence of pre-eclampsia,43 its role in GDM is still
controversial. Indeed, physical exercise combined with
diet was shown to reduce the risk of developing GDM
only if the mother was overweight or obese,44 whereas
other authors have demonstrated that physical activity
and diet are effective in reducing the incidence of
macrosomia, but not plasma glucose levels.45
However, a recent meta-analysis, including 25 studies
investigating the relation between exercising and GDM
and/or abnormal glucose tolerance, attested that regu-
lar physical activity before pregnancy and in its early
stages is effective in reducing the risk of GDM.46 These
findings suggest the need for randomized clinical stu-
dies that investigate the role of these two preventive
measures, also accounting for possible confounding
factors. However, the evidence currently available sup-
ports physical activity and nutrition as effective strate-
gies to mitigate the negative effects of pre-eclampsia
and GDM.
Pre-terms and cardiovascular outcome
Considering the increasing level of perinatal care, the
number of pre-term births has been raising over recent
years, involving around 15 million babies each year
across the world.47 Several causes that lead to an
early delivery have been identified, and one of the
most important is pre-eclampsia. However, aside from
the possible implications of pre-eclampsia, as men-
tioned earlier, several studies have attested that pre-
terms present a peculiar cardiac remodelling. Indeed,
they tend to have an increased LV mass (LVM) with
reduced volumes of both ventricles and a reduced apical
displacement.39 Furthermore, the severity of these
alterations might be correlated with the degree of pre-
maturity.48 However, the cardiovascular phenotype of
pre-term-born young adults is characterized by a pre-
served LV ejection fraction at rest, despite the geomet-
rical alterations regarding the ventricles, even if a
decrease in LV ejection fraction during increasing exer-
cise has been demonstrated.49 Huckstep et al. demon-
strated that the severity of prematurity and LV length
were predictive of this impaired LV response to phys-
ical activity.49 In pre-terms the RV seems to be more
affected than the LV:50 indeed, a lower RV myocardial
systolic strain and a lower systolic RV ejection fraction
have been reported.50 This phenomenon could be
explained at least in part by the fact that the birth
induces a profound shift from a hyperplastic growth
pattern to a hypertrophic one, and the RV switches
from being the major determinant of the cardiac
output during foetal life to supply a lower pressure cir-
culation. Another possible explanation, as mentioned
above, is the requirement of mechanical ventilation
after birth, according to the fact that one of the
major complications in pre-terms is represented by
respiratory dysfunction needing ventilation support,51
which greatly affects the right side of the heart.
Although the clinical consequences of this peculiar car-
diac phenotype in pre-terms have still to be entirely
understood, recently a possible association between
the risk of developing heart failure in young adults
and the degree of prematurity has been hypothesized,
based on the evidence that being born pre-term is asso-
ciated with an altered myocardial development.52 The
pathophysiological basis is still unclear, but animal
models have demonstrated a greater cardiomyocyte
hypertrophy and a higher interstitial myocardial fibro-
sis together with an abnormal cardiomyocyte matur-
ation.53 Another clinical implication is the higher risk
of future systemic hypertension and stroke in pre-
terms,54 as compared with full term newborns, which
is independent from the cardiac alterations.48 Increased
arterial stiffness, reduced cutaneous capillary density
and endothelial function found in pre-terms have
been indicated as factors contributing to these negative
clinical events.55 However, these pathophysiological
substrates are not entirely understood. Indeed, several
controversies exist regarding the relation between pre-
mature birth and increased aortic stiffness: while some
authors reported an increased arterial stiffness in pre-
terms, others found no differences in this parameter,
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despite a higher BP in children born prematurely.55
Therefore, future studies are needed to investigate the
impact of negative cardiac remodelling observed in pre-
terms in defining the future ASCVD risk profile of the
individual.
Pre-term: is it possible to intervene to improve
myocardial development?
Since postnatal myocardial alterations in pre-terms are
still evident in adulthood,56 it would be important to
assess whether it is possible to intervene on the cardiac
development, avoiding the persistence of this adverse
cardiac remodelling later in life. The most consistent
evidence regards the role of breast milk, since it is
responsible for improving both cardiac function and
structure in pre-term-born young adults, compared
with fed formula.57 Other experimental studies on ani-
mals have attested the possible role of pharmacological
therapies started right after birth, such as angiotensin
receptor blockers, that might have a positive effect on
cardiac development.58 Taking into account that phys-
ical exercise, in particular high-intensity exercise,
induces a cardiac remodelling caused by haemo-
dynamic changes, it would be of particular interest to
investigate whether it could influence myocardial mat-
uration in pre-terms and whether it could exert a bene-
ficial effect on the global cardiovascular profile,
lowering their risk of developing hypertensive disorders
and positively affecting structural and functional myo-
cardial remodelling.
Primordial prevention
The substrate for the development of ASCVD starts
during the early stages of life and it is influenced over
time by several, potentially modifiable, risk factors and
behaviours. Furthermore, all the efforts made towards
ASCVD prevention might have a relevant impact later
in life, further strengthening the role of primordial pre-
vention. In 2010, the American Heart Association
described ideal cardiovascular health by seven
ASCVD health metrics, suitable both for children and
adults (Table 1).59 These metrics included four behav-
ioural criteria defined as healthy, such as non-smoking,
having a BMI within normal range, being physically
active and eating a healthy diet, and three health fac-
tors, including normal BP, cholesterol profile and
plasma glucose level.59 It has been reported that
increasing the number of these ideal metrics during
childhood significantly reduces the incidence of arterial
hypertension, metabolic syndrome and dyslipidaemia.60
Furthermore, the number of metrics achieved is inver-
sely correlated with carotid intima-media thickness
(IMT) and is positively associated with arterial
elasticity.61 This evidence highlights the great impact
on arterial wall of several cardio-metabolic risk factors
developed during childhood and adolescence.62
Notably, a relevant influence on a child’s ASCVD
risk profile is the genetic patrimony inherited from
the parents. Indeed, possible mutations in genes that
exert some effects on the individual’s behaviour might
have a relevant influence in defining the risk profile.
Several studies have demonstrated the impact of gen-
etics on cardiovascular risk and, although an analysis
of the current literature on this topic is beyond the
scopes of this review, we have at least to take into
account that several studies have demonstrated that
the correlation between a child’s BMI and the BMI of
the family members is due largely to genetic influ-
ences.63,64 Another recent study has reported that gen-
etic susceptibility to develop overweight and obesity
might be correlated with appetitive traits in children,
which therefore might benefit from family counsel-
ling.65 This result stresses the tight relationship between
the genetic component and the environment, with a
close and reciprocal influence. For this reason,
although the genetic patrimony cannot be directly influ-
enced, it is important to stress the role of healthy
behaviours in the family, in order to try to at least
partially counteract inherited genetic traits that increase
the risk of developing ASCVD risk factors.
A cornerstone for supporting primary prevention is
represented by The Special Turku Coronary Risk
Factor Intervention Project for Children (STRIP)
Study, which has investigated the possible health reper-
cussions during adulthood of lifestyle changes during
the early stages of life.61 The authors demonstrated that
dietary counselling in children has a beneficial effect on
lowering plasma lipids in the long term not only in the
child but also in the parents, and in particular in the
mother,66 and it might improve insulin sensitivity
during adolescence.67 Regarding the effects on BP, as
Gillman pointed out in a recent editorial,68 there are
three major trials supporting primordial prevention: the
STRIP study,61 the Sodium Restriction Trial69 and the
Table 1. Cardiovascular health metrics described by the
American Heart Association, suitable both for children and
adults.
Behavioural criteria Health factors
Non-smoking Normal blood pressure
BMI within range Normal cholesterol profile
Being physically active Normal plasma glucose level
Healthy diet
For details see Lewandowski et al.50
BMI: body-mass index.
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Promotion of Breastfeeding Intervention (PROBIT)
trial.70 The intervention period in the first trial started
in infancy and continued through adolescence, whereas
the other two trials were limited to infancy. Both the
STRIP and the sodium restriction trial showed that
counselling on diet61 and lower-sodium formula and
baby foods69 respectively are associated with lower
BP later in life. Conversely, breastfeeding did not
show the same beneficial impact, as attested in the
PROBIT study.70
Physical activity represents a main pillar of ASCVD
prevention. Indeed, in children with levels of cholesterol
above the normal range, physical activity influenced a
decreasing trend of plasma lipids and lower BP, in a
three-year period.71 Furthermore, similar results were
obtained in obese children, since regular exercise
induced a reduction of arterial stiffness, abdominal fat
and BP, during three- and six-month follow-up.72 The
positive effects on childhood vasculature73 were particu-
larly important when long-term effects were evaluated,
since arterial stiffness is one of the major determinants
of high BP. Indeed, moderate intensity physical activity
might prevent clustering of ASCVD risk factors,74 stres-
sing the importance of starting exercising as soon as
possible. Several studies have also demonstrated that
exercise-induced cardiac remodelling can occur early
in pre-adolescents and adolescents with a significant
adaptation of the cardiovascular system starting in the
early phases of the career of a young athlete.75,76
Over the years, beyond diet and physical exercise, a
growing evidence on the efficacy of family-based inter-
ventions in ASCVD risk prevention has been demon-
strated.77 Indeed, better results have been achieved in
terms of preventing and reducing childhood obesity
when both parents or all family members were involved
in this approach, compared with strategies targeted
only on the child.78 Parents have a highly influential
role in supporting and encouraging children to adhere
to a healthy lifestyle, not only in terms of nutrition and
physical exercise, but also on the management of media
use and hours of sleep.79 Furthermore, these strategies
have a positive impact not only on the ASCVD risk
profile of the child, but also in their parents, which
makes these interventions particularly valuable and
worth endorsing.80
Taken together, the current evidence strongly sup-
ports the role of diet, regular physical exercise and
family-based intervention early in the life of a child to
control ASCVD risks and to prevent adverse cardiac
events later in life.
Adolescents and young adults
In both children and adolescents with multiple risk fac-
tors, an accelerated rate of atherosclerosis in
adulthood, documented by an increased IMT, has
been demonstrated, underlying the importance of pre-
venting the development of ASCVD risk factors at
early stages in order to prevent their negative impact
on cardiovascular health.81 The fundamental role of
nutrition and physical exercise is confirmed also at
this stage of life. Indeed, the prospect of clustered meta-
bolic risk was found to be higher in sedentary adoles-
cents compared with adolescents practising leisure-time
physical activity.82 Furthermore, Ekelund et al. showed
that the time spent practising moderate-to-vigorous
physical activity during childhood and adolescence
was associated with a better ASCVD risk profile, inde-
pendently on the amount of sedentary time.83 These
beneficial effects can be extended also to endothelial
function and IMT, since the progression of the latter
is reduced in adolescents engaged in exercise practice.84
Considering that both endothelial function and IMT
are the first steps towards an overt atherosclerosis,
these results regarding the effects of exercise are par-
ticularly promising in the context of ASCVD preven-
tion. Adolescents practising physical exercise have
wider arteriolar diameter85 together with a greater
arteriolar/venular ratio,86 both indicators of a better
retinal circulation and therefore of the systemic micro-
circulation, as compared with sedentary adolescents. In
agreement with these findings, a recent study has
proved a positive effect on the retinal microcirculation
promoting combined aerobic and coordinative exercise
during the school day, suggesting that the latter might
be a valuable measure to implement cardiovascular
health.87 In 2018 Williamson et al. designed a rando-
mized controlled trial, named Trial of Exercise to
Prevent HypeRtension in young Adults, to investigate
the effects of lifestyle changes, in particular physical
activity, on the management of BP. The results of this
trial are still non-available due to the expected
12-month follow-up,88 but they will help expand the
evidence on this topic, increasing our knowledge and
stimulating further researches and supportive clinical
strategies.
Regarding nutrition, a well-balanced and healthy
diet during adolescence has been associated with a
lower risk of developing ASCVD risk factors.89
Although in the literature controversies exist regarding
the possible benefits of fruit and vegetables, mainly due
to the heterogeneity in assessing and classifying the
consumption, a recent investigation highlighted that
avoiding sweetened beverages and following a diet
rich in fruit and vegetables might exert a cardioprotec-
tive effect in adolescents.90 Despite the complexity of
this association, several studies have attested a relation
between an unhealthy dietary pattern and a less favour-
able cardiac and metabolic profile in both children and
adolescents.91 Accordingly, combining a healthy diet
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with regular physical exercise further reduces ASCVD
risk in adolescents.92
Taken together, data currently available strongly
support a healthy diet and physical exercise as relevant
preventive strategies to protect the cardiovascular
system and to positively influence the ASCVD risk pro-
file in adulthood. Unfortunately, despite this evidence,
the number of adolescents and young adults that are
sedentary, do not follow an appropriate diet and have a
non-healthy lifestyle is increasing, describing an unex-
pected and underestimated risk scenario, even in pro-
fessional athletes.93 The scientific and clinical
community is therefore called to increase the overall
sensibility among the general population, all of the
health professionals, the politicians and all of the
people that could be potentially involved in this pro-
cess, identifying also the best strategy to reverse the
current trend and to improve cardiovascular health
and to promote the culture of early and primordial
prevention.
Limitations and conclusions
ASCVD prevention should start as soon as possible,
even before birth, considering that it can help minimize
the negative effects of risk factors on cardiovascular
health, lowering the likelihood of developing detrimen-
tal consequences which increase the chance of ASCVD
later in life. Nutrition and physical exercise are two
cornerstones of ASCVD prevention in the early
phases of our life and evidence is progressively growing,
even if, to date, solid and consistent data are still lack-
ing. However, the current promising indications could
represent a valuable starting point to design new studies
aiming to investigate the effects of primordial and early
primary prevention. Table 2 summarizes the current
evidence and gap in literature on early cardiovascular
prevention.
Practical clinical implications
The current evidence suggests the importance of pre-
venting ASCVD risk factors in children and adoles-
cents, in particular overweight and obesity, focusing
the resources on nutrition and physical activity. These
strategies should involve the whole family, not only the
child, in order to be more effective and more beneficial
for all members of the family. Furthermore, talking
directly about weight should be discouraged, and
promoting in general a healthy lifestyle rather than gen-
eralist concepts on overweight/obesity is recom-
mended.94,95 Indeed, even well-intended comments on
weight might be perceived negatively especially by ado-
lescents, and are paradoxically linked to overweight.96
Furthermore, family interventions should be supported
by public policies and strategies that incentivize healthy
diet and physical activities. For instance, building
parks, recreational spaces and biking trails could be
effective, as well as making available and more afford-
able healthy food, effectively discouraging the con-
sumption of so-called junk food.3 Table 3 summarizes
the recommendations for a healthy lifestyle based on
healthy eating habits, physical activity, appropriate
screen time and sleep habits. Unfortunately, the current
situation regarding healthy eating and proper physical
exercise among children and adolescents in Europe
does not reflect these recommendations. Compliance
with the current recommendations varies considerably
according to gender and different countries:97 for girls it
ranged from 2% in Cyprus to 14.7% in Sweden, while
for boys it ranged from 9.5% in Italy to 34.1% in
Belgium.97 In general, boys were found to be more
active than girls, who were instead engaged more com-
monly in sedentary activities, and an inverse correlation
between exercising and BMI was reported.97 Regarding
adherence to a healthy diet, a higher than expected
consumption of free sugars, mainly from fruit juices
and soft drinks, has been found.98 Finally, a low adher-
ence to the Mediterranean diet among children living in
Mediterranean countries has been demonstrated99 and
it has been recently attested that almost one in four
young obese sudden death patients show some degree
of coronary artery disease,100 further stressing that
medical doctors, scientific communities and politicians
should promote the most appropriate preventive meas-
ures to counteract this unfavourable trend that will
have a negative impact on major adverse cardiovascu-
lar events in the coming years. In Table 3 general rec-
ommendations for a healthy lifestyle and the
prevention of overweight and obesity in children,
based on healthy eating habits, physical activity, appro-
priate screen time and sleep habits, are reported.101–103
Future directions
The clinical relevance of antenatal, perinatal and prim-
ordial prevention is still developing, and it has been
growing over recent decades according to the latest evi-
dences. However, data currently available are still few
and more research is need also to identify the best prac-
tical approach to reach the aims imposed by cardiovas-
cular prevention. While the evidence on the beneficial
effects of exercise in children is growing, few data are
available about the best exercise modality to suggest in
children and pre-adolescents. Moreover, considering its
social relevance, it would be interesting to design a
study that could help better understand the role of
family behaviour and collective strategies in reducing
physical inactivity and obesity in children and in pro-
moting cardiovascular prevention. Future researches
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on the proper and optimal time to start prevention
measures, their duration and maintenance in adult-
hood, and the most effective interventions according
to the different ages will guide in the next years the
best clinical practice and the political strategies to
cope with cardiovascular disease.
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Table 3. General recommendations for a healthy lifestyle and the prevention of overweight and obesity in children, based on healthy
eating habits, physical activity, appropriate screen time and sleep habits.
Food and eating habits
 Incorporate a healthy diet made up of foods with low caloric density (vegetables, fruits, whole grains, low-fat dairy
products, lean meats, lean fish, and legumes).
 Limit foods with high caloric density (fat-rich meats, fried foods, baked goods, sweets, cheeses and oil-based sauces).
 Eat breakfast daily.
 Encourage family meals in which parents and children eat together while sitting at a table without distractions
(no television or other electronics).
 Limit eating out at restaurants, particularly fast food restaurants.
Beverages
 Avoid sugar-sweetened beverages (i.e. iced teas, sports drinks, energy drinks and juice drinks).
 Limit consumption of 100% fruit juices to appropriate portion sizes.
 Children less than 12 months of age should not drink juice unless clinically indicated.
 Encourage children to drink low-fat milk and plain tap water.
 Children less than 12 months of age should not drink cow’s milk.
 Children 1–2 years of age should drink whole milk because fat is needed for healthy growth and development.
However, in the context of obesity or strong family history of obesity, dyslipidaemia or other cardiovascular risk factors
then reduced fat (2%) milk is recommended.
 Children older than age two years should transition to low-fat (1%) or fat-free milk.
Physical activity, screen time and sleep habit
 Encourage daily practice of physical activity (from moderate to vigorous).
 Limit non-educational screen time to less than 2 h per day.
 Remove televisions and other media from the bedroom.
 Foster healthy sleep patterns.
See Anderson,101 Heyman et al.102 and Holt et al.103 for details.
Table 2. Current evidence and gap in literature on early cardiovascular prevention.
Current evidence and gap on early cardiovascular prevention
Evidence
 Prenatal exercise can reduce the incidence of pre-eclampsia and gestational diabetes
 Breast milk plays a positive role in cardiac remodelling in pre-terms
 Higher number of health metrics in childhood reduces the incidence of arterial hypertension, metabolic syndrome and
dyslipidaemia
 Dietary counselling is beneficial in children in lowering plasma lipids both in the child and the parents
 Family-based interventions are effective for cardiovascular prevention
 Moderate-to-vigorous physical activity during childhood and adolescence has positive effects on endothelial function and intima-
media thickness
 Combining physical exercise and healthy diet for the prevention of cardiovascular disease is crucial
Evidence gaps
 Optimal timing to start prevention measures is not yet clearly known
 The effects of physical exercise on cardiac remodelling in pre-term children are not clearly defined
 The best exercise modality in children is not yet clearly established
 The effects of mother’s systemic inflammation on the cardiovascular risk profile of the offspring are not completely understood
 The most effective family-based intervention needs not be determined
Evidence gaps are defined as lack of strong data currently available supporting a recommendation. Their identification is intended also as a stimulus for
the development of further research in this area.
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